Scarica l'app Stockscreener
12.05
0.74%
-0.09
Dopo l'orario di chiusura:
12.09
0.04
+0.33%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché MED Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$12.14
Aprire:
$12.04
Volume 24 ore:
50,928
Relative Volume:
0.25
Capitalizzazione di mercato:
$134.73M
Reddito:
$346.10M
Utile/perdita netta:
$-20.02M
Rapporto P/E:
-6.6107
EPS:
-1.8228
Flusso di cassa netto:
$-1.47M
1 W Prestazione:
-3.91%
1M Prestazione:
-0.33%
6M Prestazione:
+12.30%
1 anno Prestazione:
-12.74%
Intervallo 1D:
$11.88
$12.09
Intervallo di 1 settimana:
$11.88
$12.66
Portata 52W:
$9.22
$14.67
Medifast Inc Stock (MED) Company Profile
Nome
Medifast Inc
Settore
Industria
Telefono
(410) 581-8042
Indirizzo
1501 S. CLINTON STREET, BALTIMORE, MD
Compare MED vs ROL, SCI, MMED, ANDG, HRB
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MED
Medifast Inc
|
12.05 | 135.73M | 346.10M | -20.02M | -1.47M | -1.8228 |
ROL
Rollins Inc
|
34.56 | 16.62B | 3.84B | 529.30M | 621.14M | 1.0945 |
SCI
Service Corp International
|
79.73 | 10.86B | 4.33B | 535.79M | 486.05M | 3.79 |
MMED
Medifast Inc
|
22.44 | 6.40B | 0 | 0 | 0 | 0.00 |
ANDG
Andersen Group Inc
|
53.19 | 6.15B | 871.37M | -163.01M | 0 | 1.0456 |
HRB
H R Block Inc
|
44.88 | 5.56B | 3.91B | 736.10M | 760.88M | 5.6238 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-05 | Aggiornamento | DA Davidson | Underperform → Neutral |
| 2024-06-05 | Downgrade | DA Davidson | Neutral → Underperform |
| 2023-10-13 | Iniziato | Stephens | Equal-Weight |
| 2022-11-04 | Downgrade | DA Davidson | Buy → Neutral |
| 2022-08-04 | Downgrade | Jefferies | Buy → Hold |
| 2021-01-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-11-05 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2020-06-25 | Iniziato | B. Riley FBR | Buy |
| 2020-02-27 | Downgrade | Jefferies | Buy → Hold |
| 2019-11-08 | Downgrade | Dougherty & Company | Buy → Neutral |
| 2019-07-25 | Iniziato | Jefferies | Buy |
| 2018-11-08 | Aggiornamento | Sidoti | Neutral → Buy |
| 2018-03-07 | Aggiornamento | Sidoti | Neutral → Buy |
| 2017-09-15 | Reiterato | DA Davidson | Buy |
| 2016-08-04 | Reiterato | Wunderlich | Hold |
| 2016-01-11 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-11-30 | Downgrade | Sidoti | Buy → Neutral |
| 2015-10-05 | Aggiornamento | Sidoti | Neutral → Buy |
| 2014-11-07 | Downgrade | Imperial Capital | Outperform → In-line |
| 2014-08-08 | Reiterato | Imperial Capital | Outperform |
| 2014-04-23 | Reiterato | Imperial Capital | Outperform |
| 2013-09-06 | Iniziato | Imperial Capital | Outperform |
| 2012-11-06 | Reiterato | Northland Securities | Outperform |
| 2012-07-27 | Aggiornamento | Northland Securities | Market Perform → Outperform |
| 2012-07-09 | Downgrade | Standpoint Research | Buy → Hold |
| 2012-01-30 | Iniziato | Standpoint Research | Buy |
Mostra tutto
Medifast Inc Borsa (MED) Ultime notizie
BlackRock Inc. Makes New Investment in Medifast Inc $MED - MarketBeat
Medifast (MED) Reports Q2 Loss, Beats Revenue Estimates - Eastern Progress
Medifast (NYSE:MED) Stock Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
Premiumization and Strong Brands Fuel Constellation Brands' Growth - Zacks Investment Research
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth? - Yahoo Finance
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Eastern Progress
Why Is Medifast (MED) Down 7.6% Since Last Earnings Report? - Yahoo Finance
MEDIFAST INC (MED) Peer Comparison – Compare with Others - Value Research
Medifast Launches the Medifast Metabolic Health Institute - Direct Selling News
MEDIFAST INC (MED) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Medifast director Kiai Parsa buys $529k in MED stock By Investing.com - Investing.com Nigeria
Medifast (NYSE: MED) director adds 43K shares in open-market buy - Stock Titan
MEDIFAST INC (MED) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Medifast director Kiai Parsa buys $529k in MED stock - Investing.com
After 45 years of research, Medifast launches a metabolic health institute - Stock Titan
Medifast® Announces the Launch of the Medifast Metabolic Health Institute™ - Yahoo Finance
Medifast director Kiai Parsa buys $51,973 of common stock - Bitget
Steamboat Capital Partners, LLC Adds to Medifast Inc (MED) Stake -- Shares Trade 46% Above GF Value - gurufocus.com
MEDIFAST (MED) Financial Update: EPS Exceeds Its Estimate for the Current Session; Closing Reaction: Shares Move 0.42% Up on the DayRevenue Report - vinanet.vn
MED | Medifast, Inc. FinancialsRevenue Breakdown - Quiver Quantitative
Medifast (NYSE: MED) sees Steamboat Capital build 790,693-share stake - Stock Titan
Medifast (NYSE:MED) Director Purchases 43,150 Shares of Stock - MarketBeat
Insider Buying: Medifast (NYSE:MED) Director Acquires 29,337 Shares of Stock - MarketBeat
Medifast director Parsa Kiai acquires $842,698 in company shares By Investing.com - Investing.com Nigeria
Medifast director Parsa Kiai acquires $842,698 in company shares - Investing.com
Medifast (NYSE: MED) director buying near $11 — see how many shares he added - Stock Titan
Can Medifast's New Compensation Plan Accelerate Coach Growth? - TradingView
MEDIFAST (MED) Results Versus Estimates: EPS Beats Its Estimate; After Results: The Stock Records a 0.35% Increase - vinanet.vn
MEDIFAST (MED) Earnings Update: EPS Prints Above Forecast in the Latest Session; Closing Move - vinanet.vn
How the Needle is Moving on This Health and Wellness Stock: Medifast, Inc. - kalkine.com.au
MEDIFAST (MED) Holds Key Support at $10.87 as Stock Edges LowerTriple EMA - vinanet.vn
Medifast (MED): Citadel entities and Kenneth Griffin disclose sub‑5% ownership stake - Stock Titan
Susquehanna group reports 5.3% Medifast (MED) ownership in Schedule 13G - Stock Titan
Medifast (NYSE:MED) Cut to Hold at Zacks Research - MarketBeat
Medifast (MED): Charles Schwab Investment Management reports 3.6% ownership stake - Stock Titan
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth? - Yahoo Finance
Medifast’s Q2 Earnings Call: Our Top 5 Analyst Questions - finance.yahoo.com
Medifast (MED) Q2 2026 Earnings Call Transcript - AOL.com
MEDIFAST (MED) Declines 2.85% to $11.74 as Support at $11.15 Comes Under ScrutinyETF NAV Deviation - vinanet.vn
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround? - TradingView
MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building? - TradingView
Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround? - TradingView
Why Medifast (MED) Stock Is Trading Up Today - Yahoo Finance
Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade) - Seeking Alpha
Medifast rebrands flagship diet product amid pressure from GLP-1s - The Business Journals
Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves - Yahoo Finance
Medifast, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Medifast Inc (MED) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trilivy and ... By GuruFocus - Investing.com Canada
Medifast Inc (MED) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trilivy and ... - Yahoo Finance
Medifast Q2 loss widens as coach base shrinks by 48.7% - scanx.trade
Medifast Q2 Earnings Call Highlights - MarketBeat
Medifast Inc Azioni (MED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.72%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):